<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910325</url>
  </required_header>
  <id_info>
    <org_study_id>2008p001938</org_study_id>
    <nct_id>NCT00910325</nct_id>
  </id_info>
  <brief_title>Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy</brief_title>
  <official_title>Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the feasibility, safety, and efficacy of a novel minimally invasive approach to
      cholecystectomy and to establish a description of this novel translumenal technique in humans
      at this institution.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The alternative laparoscopic chole, has so little morbidity very few patients opt for a
    transvaginal approach when presented with the alternative
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The safety and efficacy of the procedure</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return to work</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to return to daily activities</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">3</enrollment>
  <condition>Cholelithiasis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic-assisted transvaginal cholecystectomy</intervention_name>
    <description>Trans-vaginal Cholecystectomy with Laparoscopic Assistance</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females who are postmenopausal or who no longer wish to bear children

          -  Females &gt;25 years old and &lt;65 years old

          -  Diagnosis of biliary disease requiring cholecystectomy

          -  American Society of Anesthesiology (ASA) Class I or II

          -  Females who are able to understand and willing to sign an informed consent document

        Exclusion Criteria:

          -  Pregnancy

          -  BMI &gt;= 30

          -  Patients who are still interested in childbearing

          -  Patients taking immunosuppressive medications or who are immunocompromised

          -  Patients with acute cholecystitis or history of acute cholecystitis ( as defined by
             right upper quadrant pain with history of fevers and/or elevated white blood cell
             count and/or positive ultrasound findings, ie, gallbladder wall thickening or
             pericholecystic fluid)

          -  Patients with suspicion of gallbladder cancer

          -  Patients with history of previous open abdominal surgery

          -  Patients with untreated common bile duct stones
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>26 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David W Rattner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <last_update_submitted>October 29, 2012</last_update_submitted>
  <last_update_submitted_qc>October 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David W. Rattner, MD</investigator_full_name>
    <investigator_title>Chief, Division of General and Gastrointestinal Surgery</investigator_title>
  </responsible_party>
  <keyword>Female</keyword>
  <keyword>Cholelithiasis</keyword>
  <keyword>Natural Orifice Surgery</keyword>
  <keyword>Laparoscopic- Assisted</keyword>
  <keyword>Transvaginal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

